Mucins in Lung Cancer Diagnostic, Prognostic, and Therapeutic Implications

被引:119
作者
Lakshmanan, Imayavaramban [1 ]
Ponnusamy, Moorthy P. [1 ]
Macha, Muzafar A. [1 ]
Haridas, Dhanya [1 ]
Majhi, Prabin Dhangada [1 ]
Kaur, Sukhwinder [1 ]
Jain, Maneesh [1 ]
Batra, Surinder K. [1 ,2 ,3 ]
Ganti, Apar Kishor [4 ,5 ]
机构
[1] VA Nebraska Western Iowa Hlth Care Syst, Dept Biochem & Mol Biol, Omaha, NE USA
[2] VA Nebraska Western Iowa Hlth Care Syst, Dept Pathol & Microbiol, Omaha, NE USA
[3] VA Nebraska Western Iowa Hlth Care Syst, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA
[4] VA Nebraska Western Iowa Hlth Care Syst, Dept Internal Med, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Dept Internal Med, Div Oncol Hematol, Omaha, NE 68198 USA
关键词
Lung cancer; Mucins; MUC1; MUC4; MUC5AC; MUC7; Mucin vaccines; L-BLP25; TG4010; Aptamer; SQUAMOUS-CELL CARCINOMA; BLP25 LIPOSOME VACCINE; MUC1; EXPRESSION; GENE-EXPRESSION; ADENOCARCINOMA; RECEPTOR; MUC5AC; STAGE; PROLIFERATION; GROWTH;
D O I
10.1097/JTO.0000000000000404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aberrant expression of mucins is associated with cancer development and metastasis. An overexpression of few mucins contributes to oncogenesis by enhancing cancer cell growth and providing constitutive survival signals. This review focuses on the importance of mucins both in the normal bronchial epithelial cells and the malignant tumors of the lung and their contribution in the diagnosis and prognosis of lung cancer patients. During lung cancer progression, mucins either alone or through their interaction with many receptor tyrosine kinases mediate cell signals for growth and survival of cancer cells. Also, stage-specific expression of certain mucins, like MUC1, is associated with poor prognosis from lung cancer. Thus, mucins are emerging as attractive targets for developing novel therapeutic approaches for lung cancer. Several strategies targeting mucin expression and function are currently being investigated to control lung cancer progression.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 79 条
[1]  
[Anonymous], TUMOUR BIOL
[2]   Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung [J].
Awaya, H ;
Takeshima, Y ;
Yamasaki, M ;
Inai, K .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (05) :644-653
[3]   The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells [J].
Bai, Chang Hoon ;
Song, Si-Youn ;
Kim, Yong-Dae .
AURIS NASUS LARYNX, 2007, 34 (02) :203-206
[4]   MUCIN BIOPHYSICS [J].
BANSIL, R ;
STANLEY, HE ;
LAMONT, JT .
ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 :635-657
[5]  
BARSKY SH, 1994, CANCER-AM CANCER SOC, V73, P1163, DOI 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO
[6]  
2-J
[7]   Intracellular MUC1 Peptides Inhibit Cancer Progression [J].
Bitler, Benjamin G. ;
Menzl, Ina ;
Huerta, Carmen L. ;
Sands, Barbara ;
Knowlton, Wendy ;
Chang, Andrew ;
Schroeder, Joyce A. .
CLINICAL CANCER RESEARCH, 2009, 15 (01) :100-109
[8]   Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J].
Brossart, P ;
Heinrich, KS ;
Stuhler, G ;
Behnke, L ;
Reichardt, VL ;
Stevanovic, S ;
Muhm, A ;
Rammensee, HG ;
Kanz, L ;
Brugger, W .
BLOOD, 1999, 93 (12) :4309-4317
[9]   Developmental mucin gene expression in the human respiratory tract [J].
Buisine, MP ;
Devisme, L ;
Copin, MC ;
Durand-Réville, M ;
Gosselin, B ;
Aubert, JP ;
Porchet, N .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (02) :209-218
[10]   Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer [J].
Butts, C ;
Murray, N ;
Maksymiuk, A ;
Goss, G ;
Marshall, E ;
Soulières, D ;
Cormier, Y ;
Ellis, P ;
Price, A ;
Sawhney, R ;
Davis, M ;
Mansi, J ;
Smith, C ;
Vergidis, D ;
Ellis, P ;
MacNeil, M ;
Palmer, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6674-6681